Boxer Capital, LLC Theseus Pharmaceuticals, Inc. Transaction History

Boxer Capital, LLC

  • $1.88 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$5.21 - $14.05 $338,650 - $913,250
-65,000 Reduced 15.66%
350,000 $3.11 Million
Q4 2022

Feb 14, 2023
SELL
$4.69 - $8.36 $2.24 Million - $3.99 Million
-477,057 Reduced 53.48%
415,000 $2.07 Million
Q4 2021

Feb 14, 2022
BUY
$8.98 - $20.09 $8.01 Million - $17.9 Million
892,057 New
892,057 $11.3 Million

Others Institutions Holding THRX

# of Institutions
2
Shares Held
1.03M
Call Options Held
0
Put Options Held
0
View Full List

About Theseus Pharmaceuticals, Inc.

THRX Quotes by TradingView
  • Ticker THRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,713,400
  • Description
  • Theseus Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of targeted therapies for the treatment of cancer patients. Its lead product candidate is THE-630, a pan-KIT inhibitor for the treatment of gastrointestinal stromal tumors, which is in Phase I clinical trial. The company also ...
More about THRX
Track This Portfolio

Track Boxer Capital, LLC Portfolio

Follow Boxer Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boxer Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boxer Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email